- Accesswire•9 days agoSeeThruEquity Initiates Coverage on Onconova Therapeutics, Inc. (NASDAQ: ONTX) with a Price Target of $5.00
NEW YORK, NY / ACCESSWIRE / January 12, 2017 / SeeThruEquity, the leading independent equity research firm focused on smallcap and microcap public companies, today announced it has initiated coverage on ...
- PR Newswire•11 days agoOnconova Therapeutics, Inc. Discusses Target Indications and Clinical Development in New SNNLive Video Interview on StockNewsNow.com
LOS ANGELES, Jan. 10, 2017 /PRNewswire/ -- StockNewsNow.com , The Official MicroCap News Source™, today published an SNNLive Video Interview with Ramesh Kumar, President & CEO of Onconova Therapeutics, ...
- GlobeNewswire•16 days ago
NEWTOWN, Pa., Jan. 05, 2017-- Onconova Therapeutics, Inc., a Phase 3 clinical stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that ...
ONTX : Summary for Onconova Therapeutics, Inc. - Yahoo Finance
Onconova Therapeutics, Inc. (ONTX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Day's Range||2.41 - 2.48|
|52 Week Range||2.11 - 8.17|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.75|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|